Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of November 2022, specifically dated November 8, 2022. The report serves to furnish a press release regarding a significant regulatory milestone for the Company's ProSense® technology in the context of Medicare coverage for breast cancer procedures.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure rather than a financial statement.
Material Changes
The primary material event disclosed is the achievement of a significant milestone in Medicare coverage for breast cancer procedures involving the Company's ProSense® technology. No financial changes versus prior periods are detailed in this document.
Guidance, Outlook, and Risks
The press release incorporated by reference includes a section titled "Forward Looking Statements," though the specific content of these statements is not reproduced in the filing text. The filing notes that certain paragraphs of the press release are incorporated into the Company's Registration Statements on Form F-3 and Form S-8.
Investor Verification Checklist
- Verify the specific details of the Medicare coverage milestone for ProSense® by reviewing Exhibit 99.1 (the press release).
- Confirm the impact of this coverage milestone on the Company's commercialization strategy and future revenue projections.
- Review the "Forward Looking Statements" section in the press release for specific risks and assumptions related to the milestone.
- Check subsequent filings for any updates on the commercial adoption of ProSense® following this coverage decision.